TissGeneSummary for ZNF282 |
Gene summary |
Basic gene information | Gene symbol | ZNF282 |
Gene name | zinc finger protein 282 | |
Synonyms | HUB1 | |
Cytomap | UCSC genome browser: 7q36.1 | |
Type of gene | protein-coding | |
RefGenes | NM_003575.2, | |
Description | HTLV-I U5 repressive element-binding protein 1HTLV-I U5RE-binding protein 1HUB-1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 603397 | |
HGNC : HGNC | ||
Ensembl : ENSG00000170265 | ||
HPRD : 04549 | ||
Vega : OTTHUMG00000158974 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ZNF282 | |
BioGPS: 8427 | ||
Pathway | NCI Pathway Interaction Database: ZNF282 | |
KEGG: ZNF282 | ||
REACTOME: ZNF282 | ||
Pathway Commons: ZNF282 | ||
Context | iHOP: ZNF282 | |
ligand binding site mutation search in PubMed: ZNF282 | ||
UCL Cancer Institute: ZNF282 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | CervixProstate | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | CESCPRAD | |
Reference showing the relevant tissue of ZNF282 | ||
Description by TissGene annotations | TissgsLTS Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for ZNF282 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for ZNF282 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for ZNF282 |
TissGeneSNV for ZNF282 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.Q90L | LIHC | 1 |
p.I321V | COAD | 1 |
p.I316V | LIHC | 1 |
p.D381Y | UCEC | 1 |
p.P186H | LUAD | 1 |
p.T351M | LGG | 1 |
p.E109K | LUAD | 1 |
p.V227A | STAD | 1 |
p.E634K | BLCA | 1 |
p.V153M | BRCA | 1 |
p.V182G | OV | 1 |
p.R87* | ESCA | 1 |
p.D135N | BLCA | 1 |
p.V108M | BLCA | 1 |
p.R329Q | GBM | 1 |
p.C548F | SARC | 1 |
p.R670Q | READ | 1 |
p.R640H | STAD | 1 |
p.G512C | BLCA | 1 |
p.P187L | BLCA | 1 |
p.G633S | UCEC | 1 |
p.S328F | HNSC | 1 |
p.D346N | HNSC | 1 |
p.M61I | OV | 1 |
p.M67L | LIHC | 1 |
p.R538C | LUAD | 1 |
p.R514H | LUAD | 1 |
p.P665L | SKCM | 1 |
p.E148K | SKCM | 1 |
p.G570V | SARC | 1 |
p.S539N | GBM | 1 |
p.H558Y | PRAD | 1 |
p.R380H | STAD | 1 |
p.T597M | LUAD | 1 |
p.N591K | BLCA | 1 |
p.I96T | COAD | 1 |
p.G636V | COAD | 1 |
p.S149N | LUSC | 1 |
p.R304W | HNSC | 1 |
p.N616D | BRCA | 1 |
p.A134D | UCEC | 1 |
p.E229D | READ | 1 |
p.G155W | UCS | 1 |
p.E211* | HNSC | 1 |
p.T139M | STAD | 1 |
p.G493D | MESO | 1 |
p.T6K | KIRP | 1 |
p.Y223D | UCEC | 1 |
p.R380H | LUAD | 1 |
p.S559T | LUAD | 1 |
p.R166K | HNSC | 1 |
p.R166K | SKCM | 1 |
p.I349N | STAD | 1 |
p.G570S | STAD | 1 |
p.R184Q | UCEC | 1 |
p.E522K | STAD | 1 |
p.G385R | LGG | 1 |
p.C557Y | STAD | 1 |
p.G598A | LUSC | 1 |
p.S357C | LUSC | 1 |
p.Q12K | ACC | 1 |
p.S577L | UCEC | 1 |
p.H592Y | READ | 1 |
p.R87Q | HNSC | 1 |
p.R506Q | PAAD | 1 |
p.V102M | LUAD | 1 |
p.R87X | ESCA | 1 |
Top |
TissGeneCNV for ZNF282 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for ZNF282 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | AA513395 | ZNF276-ZNF282 | chr16:89806250 | chr7:148922515 | |
TCGAfusionPortal | PRADA | BRCA | TCGA-D8-A1JK-01A | ZNF282-CUL1 | Out-of-frame | Chr7:148910906 | Chr7:148463653 |
Top |
TissGeneNet for ZNF282 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for ZNF282 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for ZNF282 |
TissGeneDrug for ZNF282 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for ZNF282 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0023492 | Leukemia, T-Cell | 1 | BeFree |
umls:C0023493 | Adult T-Cell Lymphoma/Leukemia | 1 | BeFree |
umls:C0040336 | Tobacco Use Disorder | 1 | GAD |